ArriVent Biopharma, Inc. Uncategorized Contracts & Agreements
7 Contracts & Agreements
- Description of Securities (Filed With SEC on March 28, 2024)
- Offer Letter Agreement, by and between the Registrant and Winston Kung, MBA, dated January 3, 2024 (Filed With SEC on January 5, 2024)
- Offer Letter Agreement, by and between the Registrant and James Kastenmayer, J.D., Ph.D., dated August 11, 2023 (Filed With SEC on January 5, 2024)
- Offer Letter Agreement, by and between the Registrant and Stuart Lutzker, M.D., Ph.D., dated May 1, 2021 (Filed With SEC on January 5, 2024)
- Offer Letter Agreement, by and between the Registrant and Robin LaChapelle, dated May 21, 2021 (Filed With SEC on January 5, 2024)
- Offer Letter Agreement, by and between the Registrant and Zhengbin (Bing) Yao, Ph.D., dated May 5, 2021 (Filed With SEC on January 5, 2024)
- ArriVent BioPharma, Inc. Clawback Policy (Filed With SEC on January 5, 2024)
